the technology is based on a technique known as ' neuromodulation ' in which electricity from a chip stimulates the nervous system to restore sight.
the revolutionary system is being commercialised by french company pixium vision , with clinical trials scheduled for 2016.
the technology is based on a technique known as ' neuromodulation ' in which electricity stimulates the nervous system to restore sight